Process integration for emerging challenges: optimal allocation of antivirals under resource constraints

ABSTRACT: The global scientific community has intensified efforts to develop, test, and commercialize pharmaceutical products to deal with the COVID-19 pandemic. Trials for both antivirals and vaccines are in progress; candidates include existing repurposed drugs that were originally developed for o...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clean Technol Environ Policy
Autori principali: Sy, C. L., Aviso, K. B., Cayamanda, C. D., Chiu, A. S. F., Lucas, R. I. G., Promentilla, M. A. B., Razon, L. F., Tan, R. R., Tapia, J. F. D., Torneo, A. R., Ubando, A. T., Yu, D. E. C.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Berlin Heidelberg 2020
Soggetti:
Original Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7292799/
https://ncbi.nlm.nih.gov/pubmed/32837502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10098-020-01876-1
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi